153 related articles for article (PubMed ID: 23307260)
1. Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer.
Zhang X; Wu Q; Gan L; Yu GZ; Wang R; Wang ZS; Wang JJ; Wang X
Med Oncol; 2013 Mar; 30(1):454. PubMed ID: 23307260
[TBL] [Abstract][Full Text] [Related]
2. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
[TBL] [Abstract][Full Text] [Related]
3. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer.
Wang X; Huang CJ; Yu GZ; Wang JJ; Wang R; Li YM; Wu Q
Hum Pathol; 2013 Oct; 44(10):2020-7. PubMed ID: 23664539
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.
Al-Moundhri MS; Al-Hadabi I; Al-Mawaly K; Kumar S; Al-Lawati FA; Bhatnager G; Kuruvila S; Al-Hamdani A; El-Sayed SM; Al-Bahrani B
Med Oncol; 2012 Sep; 29(3):1739-47. PubMed ID: 22048943
[TBL] [Abstract][Full Text] [Related]
5. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP
World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072
[TBL] [Abstract][Full Text] [Related]
9. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
10. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
12. Expression profile and prognostic role of sex hormone receptors in gastric cancer.
Gan L; He J; Zhang X; Zhang YJ; Yu GZ; Chen Y; Pan J; Wang JJ; Wang X
BMC Cancer; 2012 Dec; 12():566. PubMed ID: 23199240
[TBL] [Abstract][Full Text] [Related]
13. Expression of COX-2 in stomach cancers and its relation to their biological features.
Han SL; Tang HJ; Hua YW; Ji SQ; Lin DX
Dig Surg; 2003; 20(2):107-14. PubMed ID: 12686777
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
15. COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer.
Schildberg C; Abbas M; Merkel S; Agaimy A; Dimmler A; Schlabrakowski A; Croner R; Leupolt J; Hohenberger W; Allgayer H
J Surg Oncol; 2013 Nov; 108(6):409-13. PubMed ID: 24037722
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
[TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.
Cao XY; Ma HX; Shang YH; Jin MS; Kong F; Jia ZF; Cao DH; Wang YP; Suo J; Jiang J
World J Gastroenterol; 2014 Jul; 20(25):8201-8. PubMed ID: 25009393
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer.
Wang Y; Wang M
BMC Gastroenterol; 2016 Jul; 16(1):74. PubMed ID: 27457107
[TBL] [Abstract][Full Text] [Related]
19. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
20. The PIWI protein acts as a predictive marker for human gastric cancer.
Wang Y; Liu Y; Shen X; Zhang X; Chen X; Yang C; Gao H
Int J Clin Exp Pathol; 2012; 5(4):315-25. PubMed ID: 22670175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
